Streetbeat News

CVSI

CV Sciences Inc.

https://cvsciences.com/

Employees

71

Industry

All Other Miscellaneous Chemical Product and Preparation Manufacturing

Open

0.03

Mkt cap

6.4M

Volume

96K

High

0.04

P/E Ratio

-1.75

52-wk high

0.10

Low

0.03

Div yield

N/A

52-wk low

0.03

CV Sciences, Inc. (OTCQB:CVSI) reported a slight decline in Q1 2024 revenue to $4 million from $4.1 million in Q1 2023, alongside a net loss of $0.6 million compared to a net income of $5.7 million last year. Despite operational hurdles, the company saw a sequential revenue increase and improved gross margin to 46.3%. CV Sciences also completed the acquisition of Elevated Softgels, aiming to enhance production capabilities and drive long-term growth.

Portfolio Pulse from Patricio Liddle

May 14, 2024 | 5:40 pm

Cannabis stocks experienced significant movements on May 9, 2024, with notable gainers including Global Hemp Group, MJ Holdings, and SOL Global Investments, among others. Conversely, Auxly Cannabis Group led the losers, followed by Elixinol Wellness and CordovaCann. The movements reflect the volatile nature of the cannabis market, with companies like Canopy Growth, Cronos Group, and Aurora Cannabis also seeing gains.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 8:30 pm

Cannabis stocks showed significant movement on May 8, 2024, with Khiron Life Sciences leading the gainers with a 9900.00% increase, while The Flowr experienced a drastic 99.00% decline. Other notable movers include Affinor Growers, Eastside Distilling, and 4Front Ventures on the gainers' side, and Charlottes Web Holdings, Kaya Holdings, and Elixinol Wellness among the losers. The market saw a mix of dramatic ups and downs, reflecting the volatile nature of the cannabis industry.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 8:30 pm

Marijuana stocks experienced significant movements on May 7, 2024, with notable gainers including Kaya Holdings, Elixinol Wellness, and CV Sciences, among others. Conversely, several companies faced declines, such as Target Group, Global Compliance, and SOL Global Investments. Notable NASDAQ and NYSE listed companies like Psychemedics, Urban-gro, cbdMD, Eastside Distilling, Canopy Growth, Tilray Brands, and Scotts Miracle-Gro also saw varied stock performance.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 8:30 pm

Marijuana stocks experienced significant movement with Target Group, Global Compliance, and Heritage Cannabis Holding among the top gainers, while Item 9 Labs and Global Hemp Group led the losers. Notable NASDAQ-listed companies like Psychemedics, SNDL, Genetic Technologies, Urban-gro, Village Farms Intl, Canopy Growth, and Greenlane Holdings also saw varied price changes.

Portfolio Pulse from Benzinga Insights

May 06, 2024 | 8:30 pm

Cannabis stocks experienced significant movements on May 3, 2024, with notable gainers including Global Compliance, SOL Glb Inv, and CV Sciences, among others. Conversely, Target Group led the losers, followed by Maple Leaf Green World and Elixinol Wellness. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 8:30 pm

Marijuana stocks experienced significant movements on May 1, 2024, with notable gainers including Global Hemp Group and 22nd Century Group, while losers featured AusCann Group Holdings and Canopy Growth among others. The shifts reflect volatile market conditions in the cannabis sector.

Portfolio Pulse from Benzinga Insights

May 01, 2024 | 8:30 pm

Marijuana stocks experienced significant movements with Elixinol Wellness, Item 9 Labs, and Canopy Growth among the top gainers, while Charlotte's Web Holdings and Pharmadrug led the losers. The market saw a bullish trend for cannabis companies, with notable increases in stock prices for many firms listed on both OTC and NASDAQ.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 8:30 pm

The cannabis sector experienced mixed movements on April 29, 2024, with several companies witnessing significant gains while others faced steep declines. Notable gainers included Rocky Mountain High, Target Group, and Greenlane Holdings, with increases of 39.00%, 32.76%, and 14.76% respectively. On the downside, Global Health Clinics led the losers with a dramatic drop of 99.50%, followed by MJ Holdings and Cannabix Technologies. The fluctuations reflect a bearish sentiment across the cannabis space, impacting both NASDAQ and OTC listed companies.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 8:30 pm

Cannabis stocks experienced significant movements on April 26, 2024, with notable gainers including The Flowr, Heritage Cannabis Holding, and Greenlane Hldgs, among others. Conversely, companies like Rocky Mountain High, Cannabix Technologies, and Urban-gro were among the day's losers. This reflects the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

April 26, 2024 | 8:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.